Shelton Wealth Management »

Neurocrine Biosciences shares owned by Shelton Wealth Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Shelton Wealth Management from 13F filings

Historical chart of Shelton Wealth Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Shelton Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Shelton Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.0M 6.1k 168.54

More positions owned by Shelton Wealth Management

First Tr Exchange-traded First Tr Enh New (FTSM)
Ishares Tr Ibonds 27 Trm Ts (IBTH)
Ishares Tr Ibonds 28 Trm Ts (IBTI)
Ishares Tr Ibonds 29 Trm Ts (IBTJ)
Ishares Tr Ibonds Dec 2031 (IBTL)
Ishares Tr Ibond Dec 2030 (IBTK)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Rus 1000 Etf (IWB)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Ishares Msci Emrg Chn (EMXC)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Advanced Micro Devices (AMD)
Lam Research Corp Com New (LRCX)

View all positions for Shelton Wealth Management

Top funds holding Neurocrine Biosciences

BlackRock
Dodge & Cox
AQR Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
Renaissance Technologies
Geode Capital Management
Bnp Paribas Investment Partners
Wellington Management Company
Vestal Point Capital
Millennium Management
Northern Trust
UBS Group

View all funds holding Neurocrine Biosciences